Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib

NCT04142437 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04142437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04142437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
Lead sponsor
Bayer
Phase
Observational
Overall status
Recruiting
Start date
April 3, 2020
Completion date
March 31, 2030
Enrollment
150 (estimated)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic solid tumor harboring an ntrk gene fusion